Drugs for cardiovascular risk reduction in the diabetic patient (Q28195413)

https://scigraph.springernature.com/pub.10.1007/s11892-001-0025-7

Europe PubMed Central

title

Drugs for cardiovascular risk reduction in the diabetic patient (English)

0 references

1 reference

1 reference

D S Bell

1

0 references

language of work or name

English

0 references

publication date

October 2001

0 references

published in

Current diabetes report

0 references

volume

1

0 references

issue

2

0 references

page(s)

133-9

0 references

exact match

0 references

cites work

The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0025-7

Sudden death, impaired glucose tolerance, and diabetes in Japanese American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0025-7

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0025-7

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0025-7

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0025-7

Should angiotensin-converting enzyme inhibitors be added to the water supply of patients with diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0025-7

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0025-7

Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0025-7

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0025-7

Platelet adhesion and aggregation in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0025-7

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

12 December 2020

The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery

1 reference

12 December 2020

Why does the myocardium fail? Insights from basic science

1 reference

12 December 2020

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

12 December 2020

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

1 reference

12 December 2020

Mortality from cardiovascular diseases among diabetics

1 reference

12 December 2020

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

1 reference

12 December 2020

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

12 December 2020

Inflammation, insulin resistance, infection, diabetes, and atherosclerosis

1 reference

12 December 2020

Isradipine in prediabetic hypertensive subjects

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

1 reference

12 December 2020

Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population

1 reference

12 December 2020

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

12 December 2020

Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes

1 reference

12 December 2020

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

12 December 2020

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

12 December 2020

Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

1 reference

12 December 2020

Is there a role for beta-blockers in hypertensive diabetic patients?

1 reference

12 December 2020

Insulin resistance: syndrome or tendency?

1 reference

12 December 2020

Beta-adrenergic blocking agents in patients with diabetes-- friend and foe

1 reference

12 December 2020

Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study

1 reference

12 December 2020

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

1 reference

12 December 2020

Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment

1 reference

12 December 2020

Metabolism of low-density lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts.

1 reference

12 December 2020

Post-meal coagulation activation in diabetes mellitus: the effect of acarbose

1 reference

12 December 2020

Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients

1 reference

12 December 2020

Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide

1 reference

12 December 2020

Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine

1 reference

12 December 2020